Clinical Trials

Clinical Trials

The First-Time-in-Human Phase 1 study of SBP-101 in patients with pancreatic ductal adenocarcinoma is currently enrolling in Australia and the United States.  A dose-escalation phase is expected to precede an expansion phase at the Maximum Tolerated Dose.

Click here for more information regarding enrollment in the First-Time-in-Human Phase 1 study of SBP-101 in Australia.

Click here for more information regarding enrollment in the Phase 1 study of SBP-101 in the United States.